Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2025-01-30 Regulatory Filings
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Publication of Peer Reviewed Article
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated '30 January 2025'. It announces the 'Publication of Peer Reviewed Article' in collaboration with Merck KGaA and provides a link to the full article. The text is short and its primary function is to announce that external information (the article) has been made public, rather than being the full report itself. The presence of the RNS header and the explicit mention of RNS at the end strongly suggest this is a regulatory announcement. Since the content is an announcement about a publication, it fits best under the general 'Regulatory Filings' category (RNS) as a specific type of corporate news release, rather than a specific report type like ER or IR.
2025-01-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields typical of regulatory filings concerning changes in significant share ownership, such as '1a. Identity of the issuer', '2. Reason for the notification', '7. Total positions of person(s) subject to the notification obligation', and details about voting rights percentages. The RNS Number and reference to the FCA confirm it is a regulatory disclosure. This directly matches the definition for Major Shareholding Notification (MRQ).
2025-01-28 English
Publication of Peer Reviewed Article
Regulatory Filings Classification · 1% confidence The document is a formal announcement released via RNS (RNS Number: 8151S) on January 10, 2025. The core content is the 'Publication of Peer Reviewed Article' concerning a joint publication with Astellas Pharma Inc. in the journal 'CPT: Pharmacometrics & Systems Pharmacology'. This is not a full financial report (like 10-K or IR), nor is it a standard earnings release (ER) or a management discussion (MDA). It is an announcement about external scientific/research progress. Since it is a specific, non-financial regulatory announcement that doesn't fit the other specialized categories (like DIRS, DIV, CAP, etc.), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2025-01-10 English
Clinical Trial Approval
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 5717S' and contains an announcement dated '08 January 2025' regarding a 'Clinical Trial Approval' for an Innovate UK funded project (PREDICT-ONC). This is a specific, timely announcement of a corporate event/development that is being distributed via the Regulatory News Service (RNS). Since it is a specific announcement that doesn't fit the criteria for ER, CT, DIV, or DIRS, and it is not a full report (like 10-K or IR), the most appropriate classification is the general regulatory announcement category, RNS, as it is explicitly distributed by RNS and serves as a general regulatory update.
2025-01-08 English
Contract Award
Regulatory Filings Classification · 1% confidence The document is very short (3589 characters) and announces a 'Contract Award' between Physiomics plc and Numab Therapeutics AG regarding PK/PD modelling. It is distributed via 'RNS Number : 8828P' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief announcement of a specific corporate event distributed through the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific category like ER, 10-K, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-12-12 English
Contract Award
Regulatory Filings Classification · 1% confidence The document starts with an 'RNS Number' and is dated '05 December 2024'. It announces a 'Contract Award' for a new project valued at £157k. The content is a brief, timely announcement regarding business operations (a new contract) rather than a comprehensive financial report (like 10-K or IR) or a formal shareholder vote document. Since it is a general regulatory announcement distributed via RNS (the news service of the London Stock Exchange) and does not fit into the more specific categories like ER, CAP, or DIV, it falls best under the general Regulatory Filings category, which serves as the fallback for miscellaneous regulatory news releases.
2024-12-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.